Guger Technologies OG - mindBEAGLE: The First EEG-based BCI System Ever for Communication with Complete Locked-in Patients

Food and Healthcare Press Releases Tuesday June 13, 2017 09:01
GRAZ, Austria--13 Jun--PRNewswire/InfoQuest

Frontiers in Neuroscience recently published an article presenting mindBEAGLE as the very first and only EEG-based Brain-Computer Interface (BCI) that enables communication with patients who suffer from locked-in syndrome (LIS), complete locked-in syndrome (CLIS) or disorders of consciousness (DOC). It is widely known that these patients need BCIs that do not rely on visual stimuli and are easy to use. Paradigms based on non-visual evoked potentials and motor imagery can be effective for these patients. Therefore, mindBEAGLE has been developed and works with auditory, vibro-tactile (both based on P300) and motor-imagery paradigms in less than 20 minutes. In the study, 9 out of 12 LIS patients could communicate by using the vibro-tactile or motor-imagery paradigms. There were even 2 CLIS patients that could use the mindBEAGLE system to communicate. The results show that the system can restore communication to different patients.

(Photo: http://mma.prnewswire.com/media/521845/mindBEAGLE_Systemc.jpg )
(Photo: http://mma.prnewswire.com/media/521844/mindBEAGLE_Sujetc.jpg )

"The data reported in this paper were collected in a real world setting and demonstrate that the BCIs can revolutionize the management of several neurological disorders. Despite the substantial or complete loss of voluntary movements and speech, LIS and CLIS patients using this technology may continue to interact with the environment and participate in decisions. This achievement would represent a dramatic improvement of their quality of life." - Rossella Spataro, MD, Neurologist at the ALS Clinical Research Center, University of Palermo, Italy and co-author of this publication in the Journal of Neuroscience.

Watch the interview with Rossella Spataro and the daughter of a CLIS patient, who managed to talk to her mother with mindBEAGLE: https://www.youtube.com/watch?v=QSa3rRAT2ig&feature=youtu.be
Online Publication in Frontiers in Neuroscience: http://journal.frontiersin.org/article/10.3389/fnins.2017.00251/full
Sarah Breinbauer | Guger Technologies OG
Phone: +43 7251 222 40 | E-Mail: breinbauer@gtec.at
Press Kit: www.mindBEAGLE.at
Source: Guger Technologies OG

Latest Press Release

ESMO Publishes New Position Paper on Supportive and Palliative Care

ESMO, the leading professional organisation for medical oncology, published a position paper on supportive and palliative care [ https://doi.org/10.1093/annonc/mdx757 ], calling attention to the evolving and growing gap between the needs of cancer...

Koch Disruptive Technologies to Lead $150 Million Investment of INSIGHTEC

The medical device company is transforming neurological treatments through its non-invasive focused ultrasound applications Koch Disruptive Technologies, a subsidiary of Koch Industries focused on finding and funding innovative and emerging companies,...

MediaTek Sensio: New Biosensor Solution Brings Health Monitoring to Smartphones

MediaTek Inc. today unveiled MediaTek Sensio(TM), the first 6-in-1 smartphone biosensor module. MediaTek Sensio is a powerful advanced health monitoring solution which makes it easy to track heart rate information, blood pressure trends, peripheral...

Merck Signs Distribution Agreement with Avanti(R) Polar Lipids

Merck , a leading science and technology company, today announced that it has entered into an agreement with Avanti(R) Polar Lipids to be the exclusive multinational distributor of the USA-based company's research lipids portfolio outside of the United...

Xultophy(R) Significantly Reduces Blood Sugar Levels, Body Weight and Risk of Hypoglycaemia for People With Type 2 Diabetes in Real-World Setting

Newly published data from real-world European clinical practice has shown that Xultophy(R) (insulin degludec/liraglutide) significantly reduced blood sugar levels in people with type 2 diabetes after six months.[1] The study looked at people with type 2...

Related Topics